Rev Osteoporos Metab Miner 2011 3;2:105-112
1: Bone metabolism regulation through RANK-RANKL-OPG system
Rev Osteoporos Metab Miner 2011 3;4:165-182
2: Nutrition and osteoporosis. Calcium and vitamin D
Rev Osteoporos Metab Miner 2011 3;1:53-64
3: Position document on the requirements and optimum levels of vitamin D
Rev Osteoporos Metab Miner 2010 2;2:79-86
4: Consensual conclusions of the I Multidisciplinary Forum on the management of patients with High Risk of osteoporotic Fracture (HRF)
Suplemento Rev Osteoporos Metab Miner 2010 2;4:21-30
5: Zoledronic acid in the treatment of osteoporosis
Rev Osteoporos Metab Miner 2009 1;1:53-60
6: Clinical Practice Guidelines for Posmenopausal, Esteroid and Male Osteoporosis
Rev Osteoporos Metab Miner 2011 3;4:157-164
7: Risk of fracture according to FRAX®, hypovitaminosis D, and quality of life in a population with osteoporotic fracture cared for in primary care: baseline description of the VERFOECAP cohort
Rev Osteoporos Metab Miner 2011 3;3:2-2
8: XVI Congreso SEIOMM 2011
Rev Osteoporos Metab Miner 2011 3;4:183-188
9: Profile of action of denosumab in treatment of osteoporosis
Rev Osteoporos Metab Miner 2010 2;2:79-86
10: Consensual conclusions of the I Multidisciplinary Forum on the management of patients with High Risk of osteoporotic Fracture (HRF)
Rev Osteoporos Metab Miner 2011 3;4:157-164
11: Risk of fracture according to FRAX®, hypovitaminosis D, and quality of life in a population with osteoporotic fracture cared for in primary care: baseline description of the VERFOECAP cohort
Rev Osteoporos Metab Miner 2011 3;4:157-164
12: Risk of fracture according to FRAX®, hypovitaminosis D, and quality of life in a population with osteoporotic fracture cared for in primary care: baseline description of the VERFOECAP cohort
Rev Osteoporos Metab Miner 2011 3;4:157-164
13: Risk of fracture according to FRAX®, hypovitaminosis D, and quality of life in a population with osteoporotic fracture cared for in primary care: baseline description of the VERFOECAP cohort
Rev Osteoporos Metab Miner 2011 3;2:105-112
14: Bone metabolism regulation through RANK-RANKL-OPG system
Rev Osteoporos Metab Miner 2011 3;2:105-112
15: Bone metabolism regulation through RANK-RANKL-OPG system
Rev Osteoporos Metab Miner 2011 3;2:105-112
16: Bone metabolism regulation through RANK-RANKL-OPG system
Rev Osteoporos Metab Miner 2011 3;2:77-83
17: Appropriate use in primary care of antiresorptive drugs against osteoporosis
Rev Osteoporos Metab Miner 2010 2;2:79-86
18: Consensual conclusions of the I Multidisciplinary Forum on the management of patients with High Risk of osteoporotic Fracture (HRF)
Rev Osteoporos Metab Miner 2010 2;3:12-37
19: Póster Clínicos
Rev Osteoporos Metab Miner 2010 2;1:50-58
20: Tomographic pattern of bone permeability suggestive of secondary osteoporosis
Suplemento Rev Osteoporos Metab Miner 2010 2;2:5-17
21: Physiopathology of osteoporosis and action mechanism of PTH
Suplemento Rev Osteoporos Metab Miner 2010 2;5:19-25
22: Efficacy of bazedoxifene, pre-biphosphonate sequential therapy for osteoporosis and the patient profile for bazedoxifene
Suplemento Rev Osteoporos Metab Miner 2010 2;1:10-15
23: Bone quality and strontium ranelate
Rev Osteoporos Metab Miner 2011 3;4:141-146
24: Changes in bone metabolism markers and ultrasound parameters in postmenopausal women induced by soy isoflavones
Rev Osteoporos Metab Miner 2009 1;1:41-51
25: Osteonecrosis of the Jaw: Consensus document
< Back to last page ^Top of page